EFFECT OF PENTOXIFYLLINE ON PROTEINURIA OF DIABETIC NEPHROPATHY IN COMPARISON WITH CAPTOPRIL IN TYPE 11DIABETIC PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

REZVANIAN H.; AMIRIYANI T.; AMINI MASOUD; GHERAVI M.; AMIN ALROAYA A.; KACHOEI A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Endocrinology & Metabolism Year:2001 | Volume:3 | Issue:3 (SN 11) Page(s): 171-177

Download Full-Text

Persian Verion

View:

864

Download:

Cites:

Information Journal Paper

Title

EFFECT OF PENTOXIFYLLINE ON PROTEINURIA OF DIABETIC NEPHROPATHY IN COMPARISON WITH CAPTOPRIL IN TYPE 11DIABETIC PATIENTS

Author(s)

Keywords

PROTEINURIAQ4

DIABETESQ2

NEPHROPATHYQ3

PENTOXIFYLLINEQ4

CAPTOPRILQ4

Abstract

Diabetic NEPHROPATHY is the most common cause of ESRD. PROTEINURIA has an important role in rapid progression to ESRD. PENTOXIFYLLINE (PTX)is a drug with TNF-α suppression effect and hence reduction of PROTEINURIA and slowing of progression of diabetic NEPHROPATHY. To evaluate this hypothesis of PTXeffect in comparison with CAPTOPRIL, we studied 40 type 2 diabetics with macroPROTEINURIA (> 300 mg/day), who had no contraindication for PTX and didn't take PTX or ACEI for the past year. We didn't change the profile of DIABETES or HTN drugs of our patients. We planned a cross over study in two 2-month periods of PTX or captoril therapy spaced with a one month washout period. At beginning and the end of each treatment period we measured blood pressure, FBS, creatinine and 24-hour urine collection for volume, creatinine and protein. PTX reduced PROTEINURIA by 0.44±0.63g/day in comparison with 0.1±0.22g/day with captoprial (P =0.008). In conclusion PTX is superior than CAPTOPRIL in reducing PROTEINURIA in type 2 diabetic patients.

Cites

No record.

References

No record.

Cite

APA: Copy

REZVANIAN, H., AMIRIYANI, T., AMINI, MASOUD, GHERAVI, M., AMIN ALROAYA, A., & KACHOEI, A.. (2001). EFFECT OF PENTOXIFYLLINE ON PROTEINURIA OF DIABETIC NEPHROPATHY IN COMPARISON WITH CAPTOPRIL IN TYPE 11DIABETIC PATIENTS. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 3(3 (SN 11)), 171-177. SID. https://sid.ir/paper/27661/en

Vancouver: Copy

REZVANIAN H., AMIRIYANI T., AMINI MASOUD, GHERAVI M., AMIN ALROAYA A., KACHOEI A.. EFFECT OF PENTOXIFYLLINE ON PROTEINURIA OF DIABETIC NEPHROPATHY IN COMPARISON WITH CAPTOPRIL IN TYPE 11DIABETIC PATIENTS. IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2001;3(3 (SN 11)):171-177. Available from: https://sid.ir/paper/27661/en

IEEE: Copy

H. REZVANIAN, T. AMIRIYANI, MASOUD AMINI, M. GHERAVI, A. AMIN ALROAYA, and A. KACHOEI, “EFFECT OF PENTOXIFYLLINE ON PROTEINURIA OF DIABETIC NEPHROPATHY IN COMPARISON WITH CAPTOPRIL IN TYPE 11DIABETIC PATIENTS,” IRANIAN JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 3, no. 3 (SN 11), pp. 171–177, 2001, [Online]. Available: https://sid.ir/paper/27661/en

Related Journal Papers